XOBBAIM trademark by Pfizer Inc. (86549857) | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks
number Pfizer Inc. XOBBAIM 86549857 number Pfizer Inc. XOBBAIM 86549857

Trademark 'XOBBAIM' owned by 'Pfizer Inc.'

This page is for the XOBBAIM mark registered to Pfizer Inc..

On 2015-03-02 a trademark application was filed in Australia by Pfizer Inc.. On application the application was given number 86549857. As at the last database update (on 2017-08-18) the status of this trademark application was FOURTH EXTENSION - GRANTED.

If you would like further information about goods and services associated the XOBBAIM mark or goods and/or services provided by Pfizer Inc., please contact them directly.
2015-03-02
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
733
FOURTH EXTENSION - GRANTED
2017-08-16
2017-08-18
health her women heart care salud living advancing chas york cv mission bridge program rewards community advocacy connection cuentos starting
First 1 Last  1 of 1
NEED HELP? Chat with us online

Copyright 2008 - 2017 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.